Ian Bezek

Ian Bezek

InvestorPlace Contributor

Ian Bezek earned his economics degree from Colorado State University in 2010. He then worked as an analyst for Kerrisdale Capital, a New York City-based activist hedge fund, from 2011-13. Since then, Ian has focused on finding under-the-radar investment opportunities, particularly overseas. To that end, he taught himself Spanish and has lived in Mexico and Argentina among other countries. He currently resides in Colombia with his family.

You can interact with Ian on Twitter.

Recent Articles

Jumia Keeps Missing Earnings, But Don’t Give Up Hope Yet

By Ian Bezek, InvestorPlace Contributor

A lot of questions remain for JMIA stock. However, with one of the company's harshest critics turning into a supporter, things are looking up for Jumia.

7 of the Best Stocks to Buy as We Head Into the Holidays

By Ian Bezek, InvestorPlace Contributor

Markets are rallying into year-end as investors react to positive news. Here are seven stocks to buy for the 2020 holiday season.

Caution Is Warranted After Fisker’s 100% Spike

By Ian Bezek, InvestorPlace Contributor

Fisker's merger has closed. Now it can move on to bigger and better things. But FSR stock has gotten ahead of itself for the time being.

Up 600% Year-to-Date, Sell iBio Stock While It’s Still Flying High

By Ian Bezek, InvestorPlace Contributor

The latest iBio news isn't good. It's taken too long for IBIO to develop a coronavirus vaccine and now the opportunity has disappeared.

Hertz Stock: It’s Time To Let This One Go Already

By Ian Bezek, InvestorPlace Contributor

Hertz is progressing through the bankruptcy reorganization process. However, current Hertz stock will end up worthless as the company is restructured.

NextEra Energy Stock Looks Like a Green Energy Growth and Income Machine

By Ian Bezek, InvestorPlace Contributor

NextEra has a favorable regulatory environment and a forward-looking approach to renewables. This will help NEE stock keep running in coming years.

With Pfizer Winning the Vaccine Race, Novavax Is a Strong Sell

By Ian Bezek, InvestorPlace Contributor

Novavax made a valiant effort at developing the leading Covid-19 vaccine, but it fell short. Now poor earnings will sink NVAX stock.

Don’t Lose Your Shirt With Naked Brand Group Stock

By Ian Bezek, InvestorPlace Contributor

You shouldn't mistake a low share price for a good value. Even at 7 cents per share, NAKD stock still has farther to fall.

Don’t Get Too Excited About Marin Software’s Recent Bounce

By Ian Bezek, InvestorPlace Contributor

There's no tangible reason for the recent bounce in MRIN stock. Buyers should be careful, as the company's financial situation is precarious.

With Biden Winning, Kodak Is a Strong Sell

By Ian Bezek, InvestorPlace Contributor

Eastman Kodak's hopes were tied to a controversial scandal-plagued loan offer from the Trump Administration. As such, Kodak stock is now set to crater.

Load More